124 related articles for article (PubMed ID: 35488107)
1. Risk factors for early-onset high myopia after treatment for retinopathy of prematurity.
Matsumura S; Matsumoto T; Katayama Y; Tomita M; Morikawa H; Itokawa T; Kawakami M; Hori Y
Jpn J Ophthalmol; 2022 Jul; 66(4):386-393. PubMed ID: 35488107
[TBL] [Abstract][Full Text] [Related]
2. Does the number of laser applications for ROP treatment influence the degree of myopia?
Inoue T; Asaoka R; Hashimoto Y; Kitamoto K; Kitano M; Fujita A; Azuma K; Yamamoto K; Nagahara M; Kadonosono K; Obata R
Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):317-322. PubMed ID: 32978662
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.
Davitt BV; Dobson V; Good WV; Hardy RJ; Quinn GE; Siatkowski RM; Summers CG; Tung B;
Ophthalmology; 2005 Sep; 112(9):1564-8. PubMed ID: 16023214
[TBL] [Abstract][Full Text] [Related]
4. Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes.
Katoch D; Sanghi G; Dogra MR; Beke N; Gupta A
Indian J Ophthalmol; 2011; 59(6):423-6. PubMed ID: 22011484
[TBL] [Abstract][Full Text] [Related]
5. Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.
Chou YB; Wang AG; Yang HY; Chen KJ; Yang CS
Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3809-3816. PubMed ID: 35729410
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for myopia at 1-year corrected age following laser photocoagulation for retinopathy of prematurity.
Mori Y; Arima M; Ueda E; Fujiwara K; Seki E; Nakama T; Tsukamoto S; Akiyama M; Sonoda KH
Eye (Lond); 2021 Oct; 35(10):2820-2825. PubMed ID: 33257802
[TBL] [Abstract][Full Text] [Related]
7. Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.
Lok JYC; Yip WWK; Luk ASW; Chin JKY; Lau HHW; Young AL
Int Ophthalmol; 2018 Feb; 38(1):163-169. PubMed ID: 28054213
[TBL] [Abstract][Full Text] [Related]
8. Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity.
McLoone EM; O'Keefe M; McLoone SF; Lanigan BM
J AAPOS; 2006 Oct; 10(5):454-9. PubMed ID: 17070482
[TBL] [Abstract][Full Text] [Related]
9. Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?
Kıran Yenice E; Kara C
Int Ophthalmol; 2023 May; 43(5):1453-1458. PubMed ID: 36149616
[TBL] [Abstract][Full Text] [Related]
10. Refractive Changes among Diode Laser-treated Retinopathy of Prematurity Patients: A Retrospective Study.
Alqurashi L; Alfaraidi A; Almahmoudi F; Danish E; Hadrawi M
Middle East Afr J Ophthalmol; 2023; 30(1):37-43. PubMed ID: 38435111
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Quinn GE; Dobson V; Kivlin J; Kaufman LM; Repka MX; Reynolds JD; Gordon RA; Hardy RJ; Tung B; Stone RA
Ophthalmology; 1998 Jul; 105(7):1292-300. PubMed ID: 9663236
[TBL] [Abstract][Full Text] [Related]
12. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age.
Quinn GE; Dobson V; Davitt BV; Hardy RJ; Tung B; Pedroza C; Good WV;
Ophthalmology; 2008 Jun; 115(6):1058-1064.e1. PubMed ID: 18423871
[TBL] [Abstract][Full Text] [Related]
13. Refractive status of Chinese with laser-treated retinopathy of prematurity.
Ruan L; Shan HD; Liu XZ; Huang X
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S3-9. PubMed ID: 25756334
[TBL] [Abstract][Full Text] [Related]
14. Refractive Error Profile of Preterm Infants at 1-Year Follow-up in a Tertiary Care Hospital.
Arora P; Arora K; Utaal SKD; Bansal N
J Pediatr Ophthalmol Strabismus; 2022; 59(3):151-155. PubMed ID: 34592869
[TBL] [Abstract][Full Text] [Related]
15. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.
Geloneck MM; Chuang AZ; Clark WL; Hunt MG; Norman AA; Packwood EA; Tawansy KA; Mintz-Hittner HA;
JAMA Ophthalmol; 2014 Nov; 132(11):1327-33. PubMed ID: 25103848
[TBL] [Abstract][Full Text] [Related]
16. Refractive Error in Patients with Retinopathy of Prematurity after Laser Photocoagulation or Bevacizumab Monotherapy.
Kuo HK; Sun IT; Chung MY; Chen YH
Ophthalmologica; 2015; 234(4):211-7. PubMed ID: 26393895
[TBL] [Abstract][Full Text] [Related]
17. Development of refractive error in individual children with regressed retinopathy of prematurity.
Wang J; Ren X; Shen L; Yanni SE; Leffler JN; Birch EE
Invest Ophthalmol Vis Sci; 2013 Sep; 54(9):6018-24. PubMed ID: 23920368
[TBL] [Abstract][Full Text] [Related]
18. [A study of refractive state in premature infants without retinopathy of prematurity and full-term children at the age of 0 to 6].
Tian M; Zhou L; Luo Q; Ye M; Xu Y
Zhonghua Yan Ke Za Zhi; 2015 Jul; 51(7):505-9. PubMed ID: 26310253
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Bevacizumab, Ranibizumab, and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity in Turkey.
Gunay M; Sukgen EA; Celik G; Kocluk Y
Curr Eye Res; 2017 Mar; 42(3):462-469. PubMed ID: 27420302
[TBL] [Abstract][Full Text] [Related]
20. Long-term biometric optic components of diode laser-treated threshold retinopathy of prematurity at 9 years of age.
Yang CS; Wang AG; Shih YF; Hsu WM
Acta Ophthalmol; 2013 Jun; 91(4):e276-82. PubMed ID: 23601812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
